期刊文献+

巨细胞病毒感染与冠心病关系的Meta分析 被引量:1

Meta-Analysis on the Relationship of Cytomegalovlrus Infection and Coronary Heart Disease
下载PDF
导出
摘要 目的 采用Meta分析对国内已发表的有关巨细胞病毒(CMV)感染与冠心病(CHD) 的相关文献进行综合分析,以明确CMV感染是否为CHD危险因素。方法 全面收集有关CMV感染与CHD关系的血清流行病学研究资料,利用RevMan软件进行固定效应模型和随机效应模型的Meta分析。对不同纳入标准的结果进行了敏感性分析。结果 本研究全部文献Meta分析的OR(95%CI)为4.76(2.85~7.97);采用ELISA法、PCR法检测 CMVIgG抗体的研究资料 Meta分析的 OR(95%CI)分别为2.69(1.36~5.31),5.75(4.22~7.83);敏感性分析结果提示不同纳入标准的研究资料的Meta分析结果一致。结论 CHD患者存在CMV感染,CMV感染是CHD的一个危险因素。 Objective To determine the relationship of cytomegalovirus ( CMV) infection and coronary heart disease (CHD). Methods Seroepidemiologic studies published before 2002 that had reported on correlations between CHD and CMV were collected computer-assisted searches in CBMdisc , scanning from relevant reference lists, hand-searching from cardiology, epidemiology and other relevant journals. Combinations of key words were used in the computer searches, including cytomegalovirus, cytomegalovirus infection, coronary heart disease or coronary disease. Meta-analysis was used to systematic review, heterogeneity was assessed by the method of standard Chi-square test, and funnel plot was made to confirm publication bias. The relationship between CHD and CMV were analyzed by means of random effect model. Results 15 studies were included in this review. The involved subjects were 984, 578 patients and 406 controls. Of them the pooled ratio (OR) was 4.76 (2.85-7.97). The pooled ratio of Studies which were determined by ELISA, PCR was 2.69 (1.36-5.31), 5.75 (4.22-7.83) respectively. Conclusions CMV infection is associated with CHD, and is one of the risk factors of CHD.
出处 《浙江预防医学》 2003年第5期8-10,12,共4页 Zhejiang Journal of Preventive Medicine
关键词 巨细胞病毒感染 冠心病 危险因素 巨细胞病毒 动脉粥祥硬化 Cytomegalovirus Coronary heart disease Meta-analysis
  • 相关文献

参考文献8

  • 1富振英.Meta-Analysis研究资料的统计分析方法(一)[J].药物流行病学杂志,1994,3(4):220-222. 被引量:67
  • 2俞慧强,郑辉烈,黄鹏,袁兆康.Meta-analysis在病因流行病学中的运用[J].江西医学院学报,2001,41(1):52-52. 被引量:4
  • 3Danesh J, MBChB. Coronary heart disease, helicobaeter pylori, dental disease, chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies. Am Heart. 1999. 138:434.
  • 4Glass G V. Primary, secondary, and meta - analysis of research.Education Res, 1976, 6 (5): 3.
  • 5Zhu J, Nieto FJ, Horne BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation, 2001,103 (1): 45.
  • 6Vickers A, Goyal N, Harland R, et al. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials, 1998, 19:159.
  • 7Adam E, Melniek J L, Probtsfield J L, et al. High levels of cytomegalovius antibody in patients requiring vascular surgery for atherosclerosls. Lancet, 1987, 2 (8854): 291.
  • 8Melnick JL, Petrie BL, Dreesman GR, et al. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet, 1983, 2:644.

二级参考文献4

  • 1方积乾,医学统计学与电脑实验,1997年,232页
  • 2赵宁,数理医药学杂志,1995年,8卷,3期,230页
  • 3洪明晃,中国卫生统计,1992年,9卷,1期,57页
  • 4陈若陵,AnthonySeaton,曾光.Meta-analysis在职业肿瘤流行病学中的应用[J].中华流行病学杂志,1998,19(5):307-309. 被引量:6

共引文献68

同被引文献11

  • 1郭可赛.引用抗体捕获ELISA法测定病毒特异性IgM抗体[J].病毒学报,1987,34(1):89-91.
  • 2Maher KG, Rajiv K. Human cytomegalovims: Clinical aspects, immune regulation, and emerging treatments[J]. Lancet Infect Dis, 2004,12 (4) : 725.
  • 3Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid organ transplant recipients [ J]. Clin Microbiolgy, 2000,13 ( 1 ) : 83.
  • 4Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant [ J]. Clin Mierobiolgy,2002,15 (45) :680.
  • 5Vomhagen R, Plachter B, Hinderer W, et al. Early serodiagnosis of acute human cytomegalovims infection by enzyme-linked immunosorbent assay using recombinant antigens[J]. Clin Microbiolgy, 1994,32(4) :981.
  • 6Ripalti A, Dal Monte P, Boccuni MC, et al. Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-bindingprotein (ppUL44) and its reactivity with human antibodies[ J ]. J Virol Methods, 1994,46(1):39.
  • 7Plachter B, Klages S, Hagelmann S, et al. Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses [J]. Clin Microbiolgy, 1990,28(6) : 1229.
  • 8Plachter B, Wieczorek L, Scholl B C, et al. Detection of cytomegalovirus antibodies by an engine-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150 [ J ]. Clin Microbiolgy, 1992, 30( 1 ) :201.
  • 9Rudolph SA, Kuhn JE, Kom K, et al. Prokaryotic expression of themajor capsid protein of human cytomegalovirus and antigenic cross- reactions with herpes simplex virus type 1 [J].J Gen Virol, 1990,71 (9): 2023.
  • 10Sorenl A, Kropp H, Schwabe D, et al. Kinetics of specific immunoglobulins M, E, A and G in congenital primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-capture enzyme-inked immunosorbent assay [J]. J Clin Microbiolgy, 1988,26 (4) : 561.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部